Cure My Disease

Don't miss your cure!

 Log in / Sign up

Whey to go? protein drink tested to fight frailty in seniors

NCT ID NCT07167277

Symptom relief Sponsor: University of Kansas Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether taking 24 grams of whey protein daily for three months can improve brain antioxidant levels, physical function, and thinking skills in pre-frail adults aged 65 to 85. Twenty participants will be randomly assigned to receive either whey protein or a calorie-matched placebo powder. The goal is to see if a simple dietary supplement can help slow or reverse the signs of frailty.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
whey protein
What this could lead to
If it works, this could point toward a simple dietary supplement to help older adults maintain strength and brain function as they age.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. It is too early to know if whey protein truly helps.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pre-frail according to Fried's phenotype * Age 65 to 85 * Speak English as primary language and able to read and write in English * Stable medication for ≥ 30 days * Not already taking whey protein over the past 30 days Exclusion Criteria: * Acute or chronic kidney disease * Recent major health concerns * Insulin-requiring diabetes * Cancer requiring chemotherapy or radiation within the past 5 years * Cardiac event (i.e., MI, etc.) in the past year * Dementia or neurodegenerative disease * Clinical trial or investigational drug or therapy participation within 30 days of the screening visit or during enrollment in the current study * MRI contraindications (pacemaker, aneurysm clips, artificial heart valves, metal fragments, foreign objects or claustrophobia) * Dairy Allergy or excluding dairy from diet for other reasons * Weight \> 350 lbs. * The presence of major psychiatric disorders within the past 3 years including depression, anxiety, and alcohol (over 3 drinks/day or a total of 18 drinks/week) or drug abuse.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognition Dietary intake assessment MRI Physical function Pre-frail Pre-frail older adults

Contacts and locations

Locations

  • The University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.